TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 63 filers reported holding TCR2 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $41,245 | +47.3% | 41,295 | +162.3% | 0.00% | – |
| Q3 2022 | $28,000 | -26.3% | 15,742 | +19.2% | 0.00% | – |
| Q2 2022 | $38,000 | -87.1% | 13,201 | -79.1% | 0.00% | – |
| Q4 2021 | $294,000 | +209.5% | 63,142 | +464.1% | 0.00% | – |
| Q3 2021 | $95,000 | -83.9% | 11,193 | -68.9% | 0.00% | – |
| Q2 2021 | $591,000 | -77.1% | 36,000 | -69.2% | 0.00% | -100.0% |
| Q1 2021 | $2,583,000 | +63.8% | 116,940 | +129.4% | 0.00% | – |
| Q4 2020 | $1,577,000 | – | 50,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |